Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses. (2022)
Attributed to:
UK Biobank (core renewal)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jlr.2022.100193
PubMed Identifier: 35278410
Publication URI: http://europepmc.org/abstract/MED/35278410
Type: Journal Article/Review
Volume: 63
Parent Publication: Journal of lipid research
Issue: 5
ISSN: 0022-2275